SIGA Technologies (SIGA) stock

Market cap $241M

$3.38

+0.90%

Market closed. Prices as of Friday's close.

Quality Score

-6

Poor

In its industry

#86of 91

Pharma

Checks firing

2of 14

Trending down

From 52-week high

-63.5%

Below the 200-day

Cash$118M in cash. One of the last four quarters brought cash in while the others used it.On Jun 30

Follow SIGA's trial news. Pro members can get an alert when SIGA Technologies files news, and see its trials, share raises, and its CEO's filings.

Get an optional alert when SIGA files news on its trialFree for 24 hours. No account needed.

SIGA's Quality Score rose 1 point on Fri, Oct 2, to -6.

Cash$118M in cash. One of the last four quarters brought cash in while the others used it.On Jun 30

What's next for SIGA, and how long its cash lasts

From SIGA Technologies’s SEC filings and ClinicalTrials.gov: the company’s own words, the registry’s dates, and arithmetic, not a forecast. Companies often miss their own dates.

Its trials

A trial underway: Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOSPhase 2 · Active · 100 people · main data estimated Jan 1, 2027 · NCT04957485

For Pro members: 28 filings.

Cash runway Jun 30 balance sheet

$118M in cash

One of the last four quarters brought cash in while the others used it, so an average says little about the next.

What it means: a runway is counted only when each of the last four quarters used cash.

For Pro members: the cash used each quarter, and the math.

Dilution on the horizon

No shelf registration of its own or at-the-market program on file in the last three years.

A shelf lets a company sell shares later; an at-the-market program sells them into the market over time. Neither is a sale by itself.

For Pro members: the amounts, and the share count against a year ago.

Insiders

No open-market buys or sales by its officers or directors in their filings of the last year.

From their own Form 4 filings: buys and sales in the market, not awards or shares withheld for tax.

Get an optional alert when Diem Nguyen buys or sells

For Pro members: every trade, and Diem Nguyen’s 8 filings and quotes.

Get an optional alert when SIGA files news on its trialFree for 24 hours. No account needed.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their own filings, soonest first and small companies first.

DateStockDrug

In 27 daysFDA decisionIn 27 days · FDA decisionINOInovio PharmaceuticalsINO-3107INOInovio Pharmaceuticals · $125MINO-3107Under FDA review
In 38 daysANDA decisionIn 38 days · ANDA decisionNRXPNRX PharmaceuticalsDrug not namedNRXPNRX Pharmaceuticals · $123MDrug not namedA generic, under FDA review
In 50 daysFDA decisionIn 50 days · FDA decisionCAPRCapricor TherapeuticsDrug not namedCAPRCapricor Therapeutics · $520MDrug not namedUnder FDA review

8 more FDA dates and 114 trial data dates in the next 60 days. Pro members see every one, with the cash against its date and an optional alert before it. Get in free →

Why SIGA scores -6

PoorTrending down, 2 of 14 checks firingWhat the Quality Score means

Below -5, off the left end of the scale. Poor is below 0. Average starts at 6, Above Average at 11, Excellent at 15, and Exceptional at 20.

-6 is below -5, off the left end of the scale.

+2Chart checks 2 of 14 firing right now, one point each
−3Long-term trend below a falling 200-⁠day average, down over one year, down over two years

Size subtracts
Profit subtractsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
Growth subtractsSales and margins against a year earlier: up to +3 for fast growth and widening margins, down to -2 when both shrink.
Cash flow subtracts-1 when free cash flow over the last four quarters is negative.

No effect today: Run-up, Dilution, Volatility, Persistence, and News.

What every line is worth, and the reason behind it, on SIGA and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 1:37 AM ET, at least 15 minutes behind. How we rank stocks.

What's next

Expected to report Thu Nov 5, after the close

After its last 4 reports it closed -6.0% on average, higher 1 of 4 times.

What would turn SIGA's score around: 7 things, for Pro members

Alert me when SIGA's Quality Score turns up

Free for 24 hours. No account needed. Then keep going with a free account.

Here is what Pro members see.

Every stock has a live page like this, SIGA included: the price in real time, the full chart, all 14 checks, and every line of its score.

AMD's page for Pro members on a phone, recorded live: the price changes as it trades, beside its Quality Score and its rank, with the bid and ask under it and a year of candles below — The same page for Pro members, on AMDThe live price and the full chart, with the Quality Score drawn under it and the line that drives it.

A Pro member's stock page for AMD: its Quality Score with its rank and the line driving it, the live price with the bid and ask, the chart checks, strength, and next earnings, and a year of candles with the 21 and 50-day averages and the Quality Score drawn under the chart — The same page for Pro members, on AMDThe live price and the full chart, with the Quality Score drawn under it and the line that drives it.

The Score tab on a phone: how AMD's Quality Score adds up from price action, the company, and signals, its rank, and the chart checks by group, trend, volume, tight range, and buying — Every line of the scoreWhat each part adds, and all 14 checks by group, on SIGA and every other stock.

The New alert form on a phone: watch one name, AMD, when its Quality Score is at least 20, sent by the bell on the site, a push notification, and email, with the Save alert button — Your own optional alertsPick what to watch, SIGA or your whole watchlist, and when: a Quality Score, a price, a filing. It comes by push, email, or the bell.

Prices refresh every 2.5 seconds during market hours. Optional alerts by push, email, or the bell. Add it to your Home Screen and it opens like an app.

SIGA has 2 of 14 checks firing

One per group is shown here.

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Averages stacked in order, price near its high.

Volume1 of 3 shown

VOL VDU U/D VOL

Heavy volume on the run, quiet volume at rest.

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

The daily range is tight against its own recent history.

Buying1 of 3 shown

OBV+CLOSE HI SPRING

Closes near the high, and buyers step in on dips.

The other 10 checks on SIGA, and all 14 on every stock.Get in free →

Also on the chart

Not scored

Shown for reference. None of these counts toward the Quality Score: in our tests on 20 years of daily prices, none of them improved it.

RSI 1457.7
Above 50, below 70.
MACD (12, 26, 9)Above signal
Crossed above its signal line 34 sessions ago.
50-day average$3.14
The price is 7.6% above it.
200-day average$4.70
The price is 28.1% below it. The 50-day is below the 200-day, since Dec 23, 2025.
ADX 1424.0
Under 25, with +DI above -DI.
Support$3.01
Swing low from Jul 28, 10.9% below the price.
Resistance$3.52
Swing high from Sep 25, 4.1% above the price.
Bollinger Bands (20, 2)Inside
The bands run from $2.92 to $3.52.
Volume1.0x
Against its 20-day average, for the time of day.

How SIGA ranks in Pharma

SIGA is #86 of 91 by Quality Score. The top three are shown with their scores, and more by name.

1ABBVAbbVie8/1419
2GMABGenmab8/1415
3MRKMerck7/1413
ROIVRoivant SciencesOpen for its score
SCYXSCYNEXISOpen for its score
SLSSELLAS Life Sciences GroupOpen for its score
SNYSanofiOpen for its score
86SIGASIGA Technologies2/14-6

When does SIGA report earnings, and what happens after?

Expected to report Thu Nov 5, after the close (in 33 days). Not yet confirmed by the company.

-19.9%-3.1%+1.5%-2.2%

Nov 6Mar 10May 7Aug 6

Reported	When	Gap	Reaction	5 sessions
Aug 6, 2026After close	After close	+1.0%	-2.2%	-7.7%
May 7, 2026After close	After close	-2.0%	+1.5%	-9.9%
Mar 10, 2026After close	After close	0.0%	-3.1%	-11.2%
Nov 6, 2025After close	After close	-10.7%	-19.9%	-25.6%

The gap is the next open against the close before the report; the reaction is where that session closed. SIGA closed higher after 1 of its last 4. Past behavior, not a forecast.

Report dates and past reactions come from sessions that have already closed, so none of these figures move.

About SIGA Technologies

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

49 employeesNew York, NYsiga.com

Pro members see every line of every stock's score.

Real-⁠time prices, no delay
Every line of SIGA's score, with the points and the reason
All 14 checks on SIGA and on all 3,243 stocks
Every stock ranked, with the chart
Every filing, and optional alerts on SIGA

See all 14 checks on SIGAFree for 24 hours. No account needed. Then keep going with a free account.

Straight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, trial included, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Where does the data come from?

Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.

Do I need an account?

Not for the first 24 hours. Tap any green button and you're in, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.

Is this investment advice?

No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes. Filings are shown as filed, because a disclosure is already days or weeks old when it becomes public. Earnings dates and past reactions are settled sessions.